Across TCGA pan-cancer cohorts, LINC00687 RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated LINC00687 data layer.
The strongest signal is observed in thymoma (THYM), where higher LINC00687 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC00687 expression acts as an unfavorable survival marker, although some lineages such as UCS and LAML show a favorable association.
THYM, UCS, and LIHC are the cancer types where LINC00687 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.